TSAAI 2024 Annual Meeting
The Tennessee Society of Allergy, Asthma and Immunology (TSAAI) was established to coordinate the efforts of specialists in allergy, asthma and immunology in the state of Tennessee, principally for scientific and education purposes and to promote the highest standards of practitioners in the fields of allergy, asthma and immunology.TSAAI's annual educational meeting consists of presentations by recognized speakers in the field of allergy, asthma and immunology.
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of American College of Allergy, Asthma & Immunology and the Tenessee Society of Allergy, Asthma & Immunology (TSAAI). The American College of Allergy, Asthma & Immunology is accredited by the ACCME to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 7 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Target Audience
Practicing allergists
Allied health professionals
Learning Objectives
At the conclusion of this Activity learners should be able to…
1. Choose an affordable inhaler for most patients and recognize which biologic to choose for the right patient.
2. Understand when and how to workup difficult HAE patient cases. Become updates in education to better diagnose and treat patients with HAE.
3. Recognize novel therapeutic strategies for IgE-mediated food allergy.
4. Appreciate the nature of IgE-mediated and non-IgE-mediated adverse reactions to various vaccines.
5. Perform differential diagnosis of eosinophilic disorders and use appropriate management for these patients.
6. Understand the management of urticaria and prepare for new therapies coming in the future.
TSAAI 2024 Annual Meeting
Dollywood’s HeartSong Conference Center, Pigeon Forge, TN
August 9-11, 2024
Friday, August 9, 2024
3:30 – 5:00 pm Exhibitor setup
Conference Center
4:00 – 5:00 pm Attendee Early Check-In (Optional)
Conference Center Hallway
6:15 – 7:10 pm Welcome reception sponsored by CSL Behring (Non-CME)
Heartsong Breezeway
7:15 – 8:15 pm Product Theatre Dinner provided by CSL Behring - Non-CME
“Exploring the Burden and Management of Hereditary Angioedema: Optimizing Long-Term Prophylaxis From the Start”, John Anderson, MD
Heartsong Breezeway
Saturday, August 10, 2024
7:15 – 7:45 am Attendee Check-In
7:15 – 7:45 am Breakfast & exhibits
7:45 – 8:00 am Introduction, Ty Prince, MD
8:00 – 9:00 am The Masqueraders of Asthma, Nina Ramirez, MD
9:00 – 10:00 am Hereditary Angioedema: Where Are We Now?, Marc Riedl, MD
10:00 – 10:30 am Break & exhibits
10:30 – 11:30 am Evaluation and Management of Adverse Reactions to Vaccines, John Kelso, MD
11:30 – 12:30 pm The Latest in Food Allergy Therapy, Jay Leiberman, MD
1:00 pm Non-CME Lunch & Learn provided by Takeda
Sunday, August 11, 2024
7:15 – 8:00 am Breakfast & exhibits
8:00 – 9:00 am What the VUS?!: A Case-Based, Interactive, Practical Approach to VUS Results on Genetic Testing, Monica Lawrence, MD
9:00 – 10:00 am Evaluation of Eosinophilia, Princess Ogbogu, MD
10:00 – 10:30 am Break & exhibits
10:30 – 11:30 am Chronic Urticaria: Mechanism, Management and New Therapeutics, Farnaz Tabatabaian, MD
and Q & A
11:30 am Meeting adjourn
*please stay for a short business meeting & door prize drawing!
All relevant financial relationships with ineligible companies have been mitigated.
Monica Lawrence, MD, Speaker
Consultant: Premier Research; Researcher: Takeda
Jay Lieberman, MD, Speaker
Advisor: ARS, Aquestive, Bryn; Researcher: DBV
Princess Ogbogu, MD, Speaker
Advisor: AstraZeneca; Consultant: AstraZeneca; Researcher: AstraZeneca, GSK, Blueprint
Tidence Prince, MD, Program Chair and Planner
Speaker: CSL Behring
Nina Ramirez, MD, Speaker
Advisor: AstraZeneca, Sanofi Regeneron, Amgen; Speaker: AstraZeneca, Sanofi Regeneron
Marc Riedl, MD MS, Speaker
Consultant: Biomarin, Biocryst, CSL Behring, Kalvista, Pharvaris, Takeda, Astria, Celldex, Cycle Pharmacy, Grifols, Intellia, Pfizer, Pharming, Sanofi-Regeneron; Researcher: Biocryst, Biomarin, CSL Behring, Ionis, Kalvista, Pharvaris, Takeda; Speaker: CSL Behring, Takeda, Grifols, Pharming
Farnaz Tabatabaian, MD, Speaker
Advisor: Blueprint, Cogent, Sanofi; Speaker: Blueprint, Sanofi; Researcher: Cogent
The following have no relevant financial relationships with ineligible companies to disclose:
John Kelso, MD, Speaker
Karthik Krishnan, MD, Program Chair and Planner
Michelle Kittle, Meeting Coordinator
Chloe Miller, Meeting Coordinator
Available Credit
- 7.00 AMA PRA Category 1 Credit™
- 7.00 Attendance